Product References
TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization.
Cellular signalling
Qian H,Lu Z,Hao C,Zhao Y,Bo X,Hu Y,Zhang Y,Yao Y,Ma G,Chen L
Fri Sep 01 00:00:00 UTC 2023
TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization.
Cellular signalling
Qian H,Lu Z,Hao C,Zhao Y,Bo X,Hu Y,Zhang Y,Yao Y,Ma G,Chen L
Fri Sep 01 00:00:00 UTC 2023
TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization.
Cellular signalling
Qian H,Lu Z,Hao C,Zhao Y,Bo X,Hu Y,Zhang Y,Yao Y,Ma G,Chen L
Fri Sep 01 00:00:00 UTC 2023
Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.
Disease models & mechanisms
Jiang XY,Guan FF,Ma JX,Dong W,Qi XL,Zhang X,Chen W,Gao S,Gao X,Pan S,Wang JZ,Ma YW,Zhang LF,Lu D
Mon May 01 00:00:00 UTC 2023
Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.
Disease models & mechanisms
Jiang XY,Guan FF,Ma JX,Dong W,Qi XL,Zhang X,Chen W,Gao S,Gao X,Pan S,Wang JZ,Ma YW,Zhang LF,Lu D
Mon May 01 00:00:00 UTC 2023
Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.
Disease models & mechanisms
Jiang XY,Guan FF,Ma JX,Dong W,Qi XL,Zhang X,Chen W,Gao S,Gao X,Pan S,Wang JZ,Ma YW,Zhang LF,Lu D
Mon May 01 00:00:00 UTC 2023
TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins.
Autophagy
Lyu L,Chen Z,McCarty N
Fri Apr 01 00:00:00 UTC 2022
TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins.
Autophagy
Lyu L,Chen Z,McCarty N
Fri Apr 01 00:00:00 UTC 2022
Inhibition of SPATS2 Suppresses Proliferation and Invasion of Hepatocellular Carcinoma Cells through TRIM44-STAT3 Signaling Pathway.
Journal of Cancer
Chen L,Yi C,Li W,Tseng Y,Zhang J,Liu J
Tue Jan 05 00:00:00 UTC 2021
TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression.
Oncogene
Lyu L,Lin TC,McCarty N
Sun Aug 01 00:00:00 UTC 2021
TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression.
Oncogene
Lyu L,Lin TC,McCarty N
Sun Aug 01 00:00:00 UTC 2021
TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression.
Oncogene
Lyu L,Lin TC,McCarty N
Sun Aug 01 00:00:00 UTC 2021
MicroRNA-623 Inhibits Epithelial-Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44.
OncoTargets and therapy
Cui D,Wang K,Liu Y,Gao J,Cui J
Sun Apr 17 00:00:00 UTC 2022
TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.
Journal of neuro-oncology
Zhou X,Yang Y,Ma P,Wang N,Yang D,Tu Q,Sun B,Xiang T,Zhao X,Hou Z,Fang X
Fri Nov 01 00:00:00 UTC 2019
TRIM44 Promotes Colorectal Cancer Proliferation, Migration, and Invasion Through the Akt/mTOR Signaling Pathway.
OncoTargets and therapy
Li CG,Hu H,Yang XJ,Huang CQ,Yu XQ
Mon Apr 11 00:00:00 UTC 2022
TRIM44 Promotes Colorectal Cancer Proliferation, Migration, and Invasion Through the Akt/mTOR Signaling Pathway.
OncoTargets and therapy
Li CG,Hu H,Yang XJ,Huang CQ,Yu XQ
Mon Apr 11 00:00:00 UTC 2022
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Cancer science
Xiong D,Jin C,Ye X,Qiu B,Jianjun X,Zhu S,Xiang L,Wu H,Yongbing W
Mon Oct 01 00:00:00 UTC 2018
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Cancer science
Xiong D,Jin C,Ye X,Qiu B,Jianjun X,Zhu S,Xiang L,Wu H,Yongbing W
Mon Oct 01 00:00:00 UTC 2018
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Cancer science
Xiong D,Jin C,Ye X,Qiu B,Jianjun X,Zhu S,Xiang L,Wu H,Yongbing W
Mon Oct 01 00:00:00 UTC 2018
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Cancer science
Xiong D,Jin C,Ye X,Qiu B,Jianjun X,Zhu S,Xiang L,Wu H,Yongbing W
Mon Oct 01 00:00:00 UTC 2018
TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma.
OncoTargets and therapy
Wang H,Fang ZL,Zhang GH,Ma X
Fri Mar 18 00:00:00 UTC 2022
TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma.
OncoTargets and therapy
Wang H,Fang ZL,Zhang GH,Ma X
Fri Mar 18 00:00:00 UTC 2022
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Kawaguchi T,Komatsu S,Ichikawa D,Hirajima S,Nishimura Y,Konishi H,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Jun 01 00:00:00 UTC 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Kawaguchi T,Komatsu S,Ichikawa D,Hirajima S,Nishimura Y,Konishi H,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Jun 01 00:00:00 UTC 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Kawaguchi T,Komatsu S,Ichikawa D,Hirajima S,Nishimura Y,Konishi H,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Jun 01 00:00:00 UTC 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Kawaguchi T,Komatsu S,Ichikawa D,Hirajima S,Nishimura Y,Konishi H,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Jun 01 00:00:00 UTC 2017
TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
Oncotarget
Xing Y,Meng Q,Chen X,Zhao Y,Liu W,Hu J,Xue F,Wang X,Cai L
Tue May 24 00:00:00 UTC 2016
High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Zhu X,Wu Y,Miao X,Li C,Yin H,Yang S,Lu X,Liu Y,Chen Y,Shen R,Chen X,He S
Tue Nov 01 00:00:00 UTC 2016
High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Zhu X,Wu Y,Miao X,Li C,Yin H,Yang S,Lu X,Liu Y,Chen Y,Shen R,Chen X,He S
Tue Nov 01 00:00:00 UTC 2016
High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Zhu X,Wu Y,Miao X,Li C,Yin H,Yang S,Lu X,Liu Y,Chen Y,Shen R,Chen X,He S
Tue Nov 01 00:00:00 UTC 2016
High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Zhu X,Wu Y,Miao X,Li C,Yin H,Yang S,Lu X,Liu Y,Chen Y,Shen R,Chen X,He S
Tue Nov 01 00:00:00 UTC 2016
Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
International journal of clinical oncology
Luo Q,Lin H,Ye X,Huang J,Lu S,Xu L
Mon Jun 01 00:00:00 UTC 2015
Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
International journal of clinical oncology
Luo Q,Lin H,Ye X,Huang J,Lu S,Xu L
Mon Jun 01 00:00:00 UTC 2015
Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
International journal of clinical oncology
Luo Q,Lin H,Ye X,Huang J,Lu S,Xu L
Mon Jun 01 00:00:00 UTC 2015
Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
International journal of clinical oncology
Luo Q,Lin H,Ye X,Huang J,Lu S,Xu L
Mon Jun 01 00:00:00 UTC 2015
Novel function of Trim44 promotes an antiviral response by stabilizing VISA.
Journal of immunology (Baltimore, Md. : 1950)
Yang B,Wang J,Wang Y,Zhou H,Wu X,Tian Z,Sun B
Mon Apr 01 00:00:00 UTC 2013
Novel function of Trim44 promotes an antiviral response by stabilizing VISA.
Journal of immunology (Baltimore, Md. : 1950)
Yang B,Wang J,Wang Y,Zhou H,Wu X,Tian Z,Sun B
Mon Apr 01 00:00:00 UTC 2013
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Cancer science
Kashimoto K,Komatsu S,Ichikawa D,Arita T,Konishi H,Nagata H,Takeshita H,Nishimura Y,Hirajima S,Kawaguchi T,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Nov 01 00:00:00 UTC 2012
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Cancer science
Kashimoto K,Komatsu S,Ichikawa D,Arita T,Konishi H,Nagata H,Takeshita H,Nishimura Y,Hirajima S,Kawaguchi T,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Nov 01 00:00:00 UTC 2012
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Cancer science
Kashimoto K,Komatsu S,Ichikawa D,Arita T,Konishi H,Nagata H,Takeshita H,Nishimura Y,Hirajima S,Kawaguchi T,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Nov 01 00:00:00 UTC 2012
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Cancer science
Kashimoto K,Komatsu S,Ichikawa D,Arita T,Konishi H,Nagata H,Takeshita H,Nishimura Y,Hirajima S,Kawaguchi T,Shiozaki A,Fujiwara H,Okamoto K,Tsuda H,Otsuji E
Thu Nov 01 00:00:00 UTC 2012
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia.
Gastroenterology
Peters CJ,Rees JR,Hardwick RH,Hardwick JS,Vowler SL,Ong CA,Zhang C,Save V,O'Donovan M,Rassl D,Alderson D,Caldas C,Fitzgerald RC
Wed Dec 01 00:00:00 UTC 2010
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia.
Gastroenterology
Peters CJ,Rees JR,Hardwick RH,Hardwick JS,Vowler SL,Ong CA,Zhang C,Save V,O'Donovan M,Rassl D,Alderson D,Caldas C,Fitzgerald RC
Wed Dec 01 00:00:00 UTC 2010